Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of  -Difluoromethylornithine in Subjects with Previous History of Skin Cancer

(2010) H. H. Bailey et al.   Cancer Prevention Research

Polyamines: fundamental characters in chemistry and biology

(2009) E. Agostinelli et al.   AMINO ACIDS

Developmental alterations in expression and subcellular localization of antizyme and antizyme inhibitor and their functional importance in the murine mammary gland

(2009) Y. Murakami et al.   AMINO ACIDS

The polyamine transport system as a target for anticancer drug development

(2009) Andrew J. Palmer et al.   AMINO ACIDS

Risk of Cardiovascular Events in a Randomized Placebo-Controlled, Double-Blind Trial of Difluoromethylornithine plus Sulindac for the Prevention of Sporadic Colorectal Adenomas

(2009) J. A. Zell et al.   Cancer Prevention Research

The change of antizyme inhibitor expression and its possible role during mammalian cell cycle

(2009) Yasuko Murakami et al.   EXPERIMENTAL CELL RESEARCH

Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

(2008) Frank L. Meyskens et al.   Cancer Prevention Research

Hypoxia-Mediated Induction of the Polyamine System Provides Opportunities for Tumor Growth Inhibition by Combined Targeting of Vascular Endothelial Growth Factor and Ornithine Decarboxylase

(2008) K. J. Svensson et al.   CANCER RESEARCH

Role of ornithine decarboxylase antizyme inhibitorin vivo

(2008) Hua Tang et al.   GENES TO CELLS